151 related articles for article (PubMed ID: 11030760)
1. Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice.
Athanasopoulos T; Owen JS; Hassall D; Dunckley MG; Drew J; Goodman J; Tagalakis AD; Riddell DR; Dickson G
Hum Mol Genet; 2000 Oct; 9(17):2545-51. PubMed ID: 11030760
[TBL] [Abstract][Full Text] [Related]
2. Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7).
Evans V; Foster H; Graham IR; Foster K; Athanasopoulos T; Simons JP; Dickson G; Owen JS
Hum Gene Ther; 2008 Jun; 19(6):569-78. PubMed ID: 18578629
[TBL] [Abstract][Full Text] [Related]
3. Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE.
Harris JD; Graham IR; Schepelmann S; Stannard AK; Roberts ML; Hodges BL; Hill V; Amalfitano A; Hassall DG; Owen JS; Dickson G
Hum Mol Genet; 2002 Jan; 11(1):43-58. PubMed ID: 11772998
[TBL] [Abstract][Full Text] [Related]
4. Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.
Tsukamoto K; Smith P; Glick JM; Rader DJ
J Clin Invest; 1997 Jul; 100(1):107-14. PubMed ID: 9202062
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice.
Osman E; Evans V; Graham IR; Athanasopoulos T; McIntosh J; Nathwani AC; Simons JP; Dickson G; Owen JS
Atherosclerosis; 2009 May; 204(1):121-6. PubMed ID: 18930458
[TBL] [Abstract][Full Text] [Related]
6. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
Tsukamoto K; Tangirala R; Chun SH; Puré E; Rader DJ
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2162-70. PubMed ID: 10479659
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E delivery by peritoneal implantation of encapsulated recombinant cells improves the hyperlipidaemic profile in apoE-deficient mice.
Tagalakis AD; Diakonov IA; Graham IR; Heald KA; Harris JD; Mulcahy JV; Dickson G; Owen JS
Biochim Biophys Acta; 2005 Jan; 1686(3):190-9. PubMed ID: 15629688
[TBL] [Abstract][Full Text] [Related]
8. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
Van Eck M; Herijgers N; Van Dijk KW; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA.
Rinaldi M; Catapano AL; Parrella P; Ciafrè SA; Signori E; Seripa D; Uboldi P; Antonini R; Ricci G; Farace MG; Fazio VM
Gene Ther; 2000 Nov; 7(21):1795-801. PubMed ID: 11110410
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E.
Harris JD; Schepelmann S; Athanasopoulos T; Graham IR; Stannard AK; Mohri Z; Hill V; Hassall DG; Owen JS; Dickson G
Gene Ther; 2002 Jan; 9(1):21-9. PubMed ID: 11850719
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice.
Namiki M; Kawashima S; Yamashita T; Ozaki M; Sakoda T; Inoue N; Hirata K; Morishita R; Kaneda Y; Yokoyama M
Atherosclerosis; 2004 Jan; 172(1):21-9. PubMed ID: 14709353
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
de Beer F; van Dijk KW; Jong MC; van Vark LC; van der Zee A; Hofker MH; Fallaux FJ; Hoeben RC; Smelt AH; Havekes LM
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1800-6. PubMed ID: 10894820
[TBL] [Abstract][Full Text] [Related]
13. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
van Dijk KW; van Vlijmen BJ; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes LM; Hofker MH
Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
[TBL] [Abstract][Full Text] [Related]
14. Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in mice.
Yoshida H; Hasty AH; Major AS; Ishiguro H; Su YR; Gleaves LA; Babaev VR; Linton MF; Fazio S
Circulation; 2001 Dec; 104(23):2820-5. PubMed ID: 11733401
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors.
Kashyap VS; Santamarina-Fojo S; Brown DR; Parrott CL; Applebaum-Bowden D; Meyn S; Talley G; Paigen B; Maeda N; Brewer HB
J Clin Invest; 1995 Sep; 96(3):1612-20. PubMed ID: 7657831
[TBL] [Abstract][Full Text] [Related]
16. Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158-->Cys), and E3-Leiden.
Lee SJ; Grosskopf I; Choi SY; Cooper AD
J Lipid Res; 2004 Dec; 45(12):2199-210. PubMed ID: 15466367
[TBL] [Abstract][Full Text] [Related]
17. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
Tsukamoto K; Maugeais C; Glick JM; Rader DJ
J Lipid Res; 2000 Feb; 41(2):253-9. PubMed ID: 10681409
[TBL] [Abstract][Full Text] [Related]
18. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
Tangirala RK; Praticó D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Puré E; Rader DJ
J Biol Chem; 2001 Jan; 276(1):261-6. PubMed ID: 11024044
[TBL] [Abstract][Full Text] [Related]
19. Isoform-dependent cholesterol efflux from macrophages by apolipoprotein E is modulated by cell surface proteoglycans.
Hara M; Matsushima T; Satoh H; Iso-o N; Noto H; Togo M; Kimura S; Hashimoto Y; Tsukamoto K
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):269-74. PubMed ID: 12588770
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice.
Li B; Xu YJ; Chu XM; Gao MH; Wang XH; Nie SM; Yang F; Lv CY
Immunol Lett; 2013; 156(1-2):68-81. PubMed ID: 24084445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
